Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough? -- Ignore unavailable to you. Want to Upgrade?

To: Leslie S. Feinberg who wrote (2)	11/14/1997 5:38:00 PM
From: glen	Read Replies (1) \| Respond to of 226

Les, Vinik has supposedly taken IPO stock representing 9% of C3. I would guess he will be a further buyer of any dips. I had heard yesterday that C3 would not likely hold $15, and it is logical that Vinik knew this also. Therefore, he must like the longer term propects of C3, and did not buy for a short term pop. regards, glen

To: Leslie S. Feinberg who wrote (2)	11/14/1997 9:08:00 PM
From: dennis michael patterson	Read Replies (2) \| Respond to of 226

Leslie: The fact of the matter is that the size of the IPO was increased by 50% AND was priced at the high end of the range (and this for a company with no earnings!!). I passed on the IPO as did others. As for Glen's claims about things getting better down the road, well, as I read his posts on the Cree thread, this IPO was supposed to be "hot!hot!hot!" It was not. Paulson made a bundle. The brothers made a bundle, and the buyers got a dud. Cree was the second best stock I've ever had (GPTX is the first). I rode CREE up from 15 (pre-split) and rode it down to 9. C3 will never be Cree IMHO. And finally, all the talk about Vinik doesn't mean anything. He just lost over 50 percent of his investment last week in last week in RFMI. So, be cautious!